TipRanks
UG Healthcare Corp. Ltd. (SG:8K7)
SGX:8K7
Singapore Market
8K7
UG Healthcare Corp. Ltd.
RESEARCH TOOLSreports
Want to see SG:8K7 full AI Analyst Report?

UG Healthcare Corp. Ltd. (8K7) Ratios

0 Followers

UG Healthcare Corp. Ltd. Ratios

SG:8K7's free cash flow for Q2 2024 was S$0.16. For the 2024 fiscal year, SG:8K7's free cash flow was decreased by S$ and operating cash flow was S$-0.12. See a summary of the company’s cash flow.
Ratios
TTM
Jun 26Jun 25Jun 24Jun 23
Liquidity Ratios
Current Ratio
 2.82 2.82 2.70 3.83 4.88
Quick Ratio
 1.61 1.61 1.44 2.23 3.22
Cash Ratio
 0.56 0.56 0.45 0.73 1.88
Solvency Ratio
 0.11 0.11 >-0.01 -0.03 -0.35
Operating Cash Flow Ratio
 0.36 0.36 -0.09 -0.48 -1.19
Short-Term Operating Cash Flow Coverage
 0.82 0.82 -0.20 -1.01 -2.43
Net Current Asset Value
S$ 66.34MS$ 66.34MS$ 62.18MS$ 81.00MS$ 111.13M
Leverage Ratios
Debt-to-Assets Ratio
 0.17 0.17 0.20 0.19 0.14
Debt-to-Equity Ratio
 0.24 0.24 0.30 0.27 0.17
Debt-to-Capital Ratio
 0.19 0.19 0.23 0.21 0.15
Long-Term Debt-to-Capital Ratio
 0.10 0.10 0.12 0.13 0.07
Financial Leverage Ratio
 1.40 1.40 1.46 1.39 1.27
Debt Service Coverage Ratio
 0.42 0.42 0.06 -0.19 -1.32
Interest Coverage Ratio
 2.19 2.19 -0.37 -5.17 -27.45
Debt to Market Cap
 0.84 0.84 0.69 0.56 0.33
Interest Debt Per Share
 0.07 0.07 0.08 0.07 0.05
Net Debt to EBITDA
 1.15 1.15 9.73 -3.99 1.28
Profitability Margins
Gross Profit Margin
28.42%28.42%24.11%22.45%1.43%
EBIT Margin
3.68%3.68%-0.87%-6.78%-27.14%
EBITDA Margin
7.57%7.57%1.72%-3.42%-23.70%
Operating Profit Margin
3.68%3.68%-0.57%-5.75%-24.84%
Pretax Profit Margin
2.65%2.65%-2.39%-7.89%-28.59%
Net Profit Margin
1.39%1.39%-2.63%-5.26%-20.50%
Continuous Operations Profit Margin
1.76%1.76%-3.07%-7.56%-27.21%
Net Income Per EBT
52.44%52.44%110.29%66.63%71.70%
EBT Per EBIT
72.04%72.04%421.57%137.13%115.12%
Return on Assets (ROA)
0.87%0.87%-1.63%-2.67%-9.01%
Return on Equity (ROE)
1.27%1.22%-2.39%-3.71%-11.47%
Return on Capital Employed (ROCE)
2.90%2.90%-0.45%-3.52%-12.74%
Return on Invested Capital (ROIC)
1.72%1.72%-0.40%-3.10%-11.17%
Return on Tangible Assets
0.96%0.96%-1.78%-2.91%-9.04%
Earnings Yield
4.37%4.37%-5.58%-7.96%-23.08%
Efficiency Ratios
Receivables Turnover
 2.98 2.98 3.04 2.26 2.60
Payables Turnover
 4.24 4.24 4.24 6.46 11.43
Inventory Turnover
 1.83 1.83 1.70 1.46 1.83
Fixed Asset Turnover
 2.33 2.33 2.34 2.00 1.69
Asset Turnover
 0.63 0.63 0.62 0.51 0.44
Working Capital Turnover Ratio
 1.72 1.72 1.48 0.98 0.67
Cash Conversion Cycle
 235.73 235.73 249.17 355.70 308.29
Days of Sales Outstanding
 122.62 122.62 120.14 161.74 140.51
Days of Inventory Outstanding
 199.10 199.10 215.09 250.50 199.71
Days of Payables Outstanding
 85.99 85.99 86.07 56.54 31.94
Operating Cycle
 321.72 321.72 335.24 412.24 340.23
Cash Flow Ratios
Operating Cash Flow Per Share
 0.03 0.03 >-0.01 -0.03 -0.06
Free Cash Flow Per Share
 0.02 0.02 -0.01 -0.03 -0.08
CapEx Per Share
 <0.01 <0.01 <0.01 <0.01 0.01
Free Cash Flow to Operating Cash Flow
 0.85 0.85 1.70 1.14 1.21
Dividend Paid and CapEx Coverage Ratio
 6.72 6.72 -1.44 -7.11 -3.26
Capital Expenditure Coverage Ratio
 6.72 6.72 -1.44 -7.11 -4.88
Operating Cash Flow Coverage Ratio
 0.43 0.43 -0.10 -0.42 -1.26
Operating Cash Flow to Sales Ratio
 0.12 0.12 -0.03 -0.16 -0.39
Free Cash Flow Yield
31.16%31.16%-11.92%-27.21%-52.51%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 22.65 22.65 -17.87 -12.57 -4.33
Price-to-Sales (P/S) Ratio
 0.32 0.32 0.47 0.66 0.89
Price-to-Book (P/B) Ratio
 0.28 0.28 0.43 0.47 0.50
Price-to-Free Cash Flow (P/FCF) Ratio
 3.21 3.21 -8.39 -3.68 -1.90
Price-to-Operating Cash Flow Ratio
 2.73 2.73 -14.23 -4.19 -2.30
Price-to-Earnings Growth (PEG) Ratio
 0.23 -0.15 0.48 0.18 0.03
Price-to-Fair Value
 0.28 0.28 0.43 0.47 0.50
Enterprise Value Multiple
 5.36 5.36 37.23 -23.34 -2.47
Enterprise Value
 61.14M 61.14M 92.07M 91.82M 59.21M
EV to EBITDA
 5.36 5.36 37.23 -23.34 -2.47
EV to Sales
 0.41 0.41 0.64 0.80 0.59
EV to Free Cash Flow
 4.08 4.08 -11.35 -4.43 -1.26
EV to Operating Cash Flow
 3.48 3.48 -19.26 -5.06 -1.51
Tangible Book Value Per Share
 0.24 0.24 0.22 0.23 0.29
Shareholders’ Equity Per Share
 0.28 0.28 0.25 0.26 0.29
Tax and Other Ratios
Effective Tax Rate
 0.34 0.34 -0.28 0.03 0.05
Revenue Per Share
 0.24 0.24 0.23 0.18 0.16
Net Income Per Share
 <0.01 <0.01 >-0.01 >-0.01 -0.03
Tax Burden
 0.52 0.52 1.10 0.67 0.72
Interest Burden
 0.72 0.72 2.74 1.16 1.05
Research & Development to Revenue
 0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
 0.25 0.25 0.25 0.21 0.20
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 8.38 8.38 1.39 2.00 1.89
Currency in SGD